Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2019)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-06-05 |
Court | District Court, D. Delaware | Date Terminated | 2020-01-09 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 8,436,010; 8,778,962 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-01-12 | 15 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,778,962; 8,436,010. (Attachments…2019 10 January 2020 1:19-cv-01042 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2019-06-05 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,778,962; 8,436,010. (nmg) (…2019 10 January 2020 1:19-cv-01042 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |